First call for papers can be downloaded here Call for Papers - PDF version
Second call for papers can be downloaded here Call for Papers - PDF version

The novel coronavirus SARS-CoV-2 causes a severe, potentially fatal acute respiratory syndrome, COVID-19, that has paralyzed our societies, leading to prolonged self-isolation and quarantine.

The Annual Reviews in Control, an IFAC journal, is calling for invited papers on how control systems and bioengineering can contribute, or are already contributing, to meeting the challenges of COVID-19 in a Special Issues: Special Issue on Systems & Control Research Efforts Against COVID-19 and Future Pandemics.

The call is being led by several members of the IFAC Technical Committee 8.2.

Detailed information about the Special Issue can be found here


We are living in challenging, yet sensational and inspiring times. No doubt the year ahead is going to change the view we have on our lives and that on our environment. More than ever medical and biological systems stay at the core of our societal and economical challenges. No longer these can progress without the interdisciplinarity among them, and progress itself cannot be enabled without the inter-modularity with engineering and computing. Healthcare systems, biological systems, pharmaceutical systems and everything stemming from these are welcomed topics to our 11th IFAC Symposium on Biological and Medical Systems (BMS2021), organized in Ghent, Belgium, through 19-22 September 2021.

BMS2021 features three main themes to provide latest results in context of personalized medicine and personalized medication production processes:
- drug delivery systems: includes modelling, control, analysis and pharmacological studies, medical devices, clinical trial results;
- combined cancer therapy: includes nanomedicine, radiation, immunology, stem cells, modelling and control, medical devices and robotics, clinical trial results;
- pharmaceutical processes: includes process modelling, process control, bio-chemical process optimization, instrumentation.

Experimental, clinical and feasibility studies are particularly welcome contributions. The symposium covers all aspects of biomedicine, physiology, biology, pharmaceutical and epidemiological problems interconnected through multidisciplinarity with systems engineering.

The technical program will comprise several types of presentations in regular and invited sessions, tutorial sessions, and special sessions along with workshops and exhibits. An important goal of the conference is to emphasize the enabling role of engineering and control in the emerging Pharma 4.0 context and listen to the challenges from both industry and academia.

The symposium will address the latest progress and challenges posed in all themes of technical committees:
- model formulation, experiment design, identification and validation, biosignal analysis and interpretation,
- advances in sensing and signal processing,
- tracer kinetic modelling from imaging systems,
- biomedical system modelling, simulation and visualization,
- decision support systems and feedback control
- robotics, devices and sensors,
- biological systems and controls, etc.
- pharmaceutical processes,
- on demand product manufacturing and quality control,
- artificial intelligence for decision support systems,
- bionic engineering and biomaterials.

Application areas may include, but not limited to:
- cellular, metabolic, cardiovascular, neurosystems,
- healthcare management and delivery, disease control, critical care,
- pharmacokinetics and drug delivery,
- decision support systems for the control of physiological and clinical variables,
- biomedical imaging systems,
- intensive and chronic therapy,
- medical information systems,
- surgical robotics and medical nano-robotics,
- control of voluntary movements, respiration, locomotion,
- rehabilitation engineering including rehabilitation robotics,
- kinetic modelling and control of biological systems, artificial organs and biomechanical systems,
- quantification of physiological parameters for diagnosis assessment,
- production optimization in pharmaceutical industry
- pharmaceutical product on demand, design,
manufacturing and quality assessment,
- targeted molecular therapies,
- artificial intelligence support in diagnosis and decision making systems.

Benchmark Challenge Competition
The symposium will feature a benchmark challenge addressed to all doctoral students who plan to attend the event. A competition will be organized and featured in a special session.

Important dates:

  submission opens (regular papers, invited papers):   October 1st, 2020
  submission opens for OIT (open invited track) proposals:   October 1st, 2020
  OIT proposal deadline:   November 1st, 2020
  registration site opens:   January 1st, 2021
  draft paper submission deadline:   January 24th, 2021
  submission opens for final papers:   March 1st, 2021
  final paper submission deadline:   May 1st, 2021


More information about the IFAC activities can be found here





UGent FWO IMEC GZA Iridium


CESPE CESPE